Application Information

This drug has been submitted to the FDA under the reference 062759/001.

Names and composition

"ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL" is the commercial name of a drug composed of ERYTHROMYCIN ETHYLSUCCINATE and SULFISOXAZOLE ACETYL.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
062759/001 ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL GRANULE/ORAL EQ 200MG BASE per 5ML and EQ 600MG BASE per 5ML

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
050529/001 PEDIAZOLE ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL GRANULE/ORAL EQ 200MG BASE per 5ML and EQ 600MG BASE per 5ML
062758/001 ERYZOLE ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL GRANULE/ORAL EQ 200MG BASE per 5ML and EQ 600MG BASE per 5ML
062759/001 ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL GRANULE/ORAL EQ 200MG BASE per 5ML and EQ 600MG BASE per 5ML

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved